Development of a metabolomics-based data analysis approach for identifying drug metabolites based on high-resolution mass spectrometry
Journal of Food and Drug Analysis · 10.03.2023 · 31 (1) · 152-164
DOI: 10.38212/2224-6614.3451 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Food and Drug Analysis, online erschienen am 10.03.2023. Verfasst von Hsiao-Hsien Ting und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi City 60002, Taiwan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
A metabolomics-based approach to data analysis is required for drug metabolites to be identified quickly. This study developed such an approach based on high-resolution mass spectrometry. Our approach is a two-stage one that combines a time-course experiment with stable isotope tracing. Pioglitazone (PIO) was used to improve glycemic management for type 2 diabetes mellitus. Consequently, PIO was taken as a model drug for identifying metabolites. During Stage I of data analysis, 704 out of 26626 ions exhibited a positive relationship between ion abundance ratio and incubation time in a time-course experiment. During Stage II, 25 isotope pairs were identified among the 704 ions. Among these 25 ions, 18 exhibited a dose-response relationship. Finally, 14 of the 18 ions were verified to be PIO structure-related metabolite ions. Otherwise, orthogonal partial least squares-discriminant analysis (OPLS-DA) was adopted to mine PIO metabolite ions, and 10 PIO structure-related metabolite ions were identified. However, only four ions were identified by both our developed approach and OPLS-DA, indicating that differences in the designs of metabolomics-based approaches to data analysis can result in differences in which metabolites are identified. A total of 20 PIO structure-related metabolites were identified by our developed approach and OPLS-DA, and six metabolites were novel. The results demonstrated that our developed two-stage data analysis approach can be used to effectively mine data on PIO metabolite ions from a relatively complex matrix.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi City 60002, Taiwan.
- Master Degree Program in Toxicology, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
- Clinical Research Center, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi City 60002, Taiwan.
- Department of Chemistry and Biochemistry, National Chung Cheng University, Chiayi 621301, Taiwan.
Zitieren
APA
Ting, H. H., Chiou, Y. S., Chang, T. Y., Lin, G. Y., Li, P. J., & Shih, C. L. (2023). Development of a metabolomics-based data analysis approach for identifying drug metabolites based on high-resolution mass spectrometry. Journal of Food and Drug Analysis, 31(1), 152-164. https://doi.org/10.38212/2224-6614.3451
Vancouver
Ting HH, Chiou YS, Chang TY, Lin GY, Li PJ, Shih CL. Development of a metabolomics-based data analysis approach for identifying drug metabolites based on high-resolution mass spectrometry. Journal of Food and Drug Analysis. 2023;31(1):152-164. doi:10.38212/2224-6614.3451
BibTeX
@article{Ting2023,
author = {Ting, Hsiao-Hsien and Chiou, Yi-Shiou and Chang, Tien-Yi and Lin, Guan-Yu and Li, Pei-Jhen and Shih, Chia-Lung},
title = {Development of a metabolomics-based data analysis approach for identifying drug metabolites based on high-resolution mass spectrometry},
journal = {Journal of Food and Drug Analysis},
year = {2023},
volume = {31},
number = {1},
pages = {152--164},
doi = {10.38212/2224-6614.3451}
}
EUVIMED